<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04924127</url>
  </required_header>
  <id_info>
    <org_study_id>KY2019-539</org_study_id>
    <nct_id>NCT04924127</nct_id>
  </id_info>
  <brief_title>Molecular Pathology Research Project of Glioma</brief_title>
  <official_title>Exploring the Feasibility of the Molecular Pathology Model of Patients With Glioma Via Retrospective Research</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jinsong Wu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Huashan Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Exploring the feasibility of the molecular pathology model of patients with glioma via&#xD;
      retrospective research.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Exploring the feasibility of the molecular pathology model of patients with glioma via&#xD;
      retrospective research. This section will include 490 frozen tissue samples of patients with&#xD;
      different grades of glioma for IDH, TERT and 1p19q mutation detection, matching blood&#xD;
      samples, and related clinical information and follow-up information. Compare with the&#xD;
      existing molecular pathology system, analyze the combination of IDH and TERT mutations and&#xD;
      the feasibility of stratifying the prognosis of patients with glioma.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 5, 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Actual">June 6, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Detection the status of IDH (Isocitrate Dehydrogenase), TERT (Telomerase Reverse Transcriptase) and 1p19q (chromosome arms 1p and 19q)</measure>
    <time_frame>through study completion, an average of 1 week</time_frame>
    <description>To explore the feasibility of using the mutations of IDH and TERT to replace the role of 1p19q in glioma molecular pathology</description>
  </primary_outcome>
  <enrollment type="Anticipated">790</enrollment>
  <condition>Glioma, Malignant</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Detection of IDH and TERT mutation</intervention_name>
    <description>Detection of IDH and TERT mutation using frozen glioma tissues</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Glioma patient from Huashan Hospital with Informed Consent Form&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of Glioma&#xD;
&#xD;
          -  Glioma patient with long-term follow-up data and intact clinical data&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Glioma patient without Informed Consent Form&#xD;
&#xD;
          -  Glioma patient without long-term follow-up data or intact clinical data&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jin-song Wu, MD &amp; PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Huashan Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shuai Wu, MD &amp; PhD</last_name>
    <phone>86-15316051226</phone>
    <email>wushuai0606@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Huashan Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Jingan District</state>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shuai Wu, MD &amp; PhD</last_name>
      <phone>021-52888045</phone>
      <email>wushuai0606@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>May 23, 2021</study_first_submitted>
  <study_first_submitted_qc>June 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 11, 2021</study_first_posted>
  <last_update_submitted>November 10, 2021</last_update_submitted>
  <last_update_submitted_qc>November 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Huashan Hospital</investigator_affiliation>
    <investigator_full_name>Jinsong Wu</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <keyword>Molecular pathology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glioma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

